DiamiR Announces Publication of Data on microRNA Biomarkers for Rett Syndrome

MONMOUTH JUNCTION, N.J., July 11, 2019 /PRNewswire/ — DiamiR, a developer of innovative blood-based diagnostic tests for neurological and other diseases, announced today the publication of “Brain-enriched microRNAs circulating in plasma as novel biomarkers for Rett syndrome” in PLOS ONE [https://doi.org/10.1371/journal.pone.0218623].